CMS Guidelines on Drug Set-asides in MSAs Raise Industry Concerns

Leaders in the workers' compensation Medicare set-aside industry are calling upon the federal government to reconsider its recently issued guidelines to estimate future drug costs, saying the agency's reliance on a wholesale-price benchmark will cause settlement costs to skyrocket.Centers for Medicare and Medicaid Services (CMS) on April 3 issued a memorandum saying that after three years of virtually ignoring the drug component required for inclusion in Medicare set-asides (MSAs) that regulators — with less than 60 days warning — would begin to evaluate projections for fut...